The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients

Authors :: Dhooge, P.P.A.
Moller, P.
Boon, C.J.F.
Lotery, A.J.
Herrmann, P.
Battaglia Parodi, M.
Klein, Wolfgang
Fsadni, M.G.
Wheeler-Schilling, T.H.
Jungman, O.
Muller, Hans
Holz, F.G.
Schmitz-Valckenberg, S.
Peters, T.M.
Stingl, Katarina
Hoyng, C.B.
Dhooge, P.P.A.
Moller, P.
Boon, C.J.F.
Lotery, A.J.
Herrmann, P.
Battaglia Parodi, M.
Klein, Wolfgang
Fsadni, M.G.
Wheeler-Schilling, T.H.
Jungman, O.
Muller, Hans
Holz, F.G.
Schmitz-Valckenberg, S.
Peters, T.M.
Stingl, Katarina
Hoyng, C.B.
Source :: Open Research Europe; 2732-5121; 1; 96; ~Open Research Europe~~~~~2732-5121~~1~~96
Publication Year :: 2021
Abstract: Contains fulltext : 246489.pdf (Publisher’s version ) (Open Access)

Database :: OAIster
Journal :: Open Research Europe; 2732-5121; 1; 96; ~Open Research Europe~~~~~2732-5121~~1~~96
Publication Type :: Electronic Resource
Accession number :: edsoai.on1296112692
Document Type :: Electronic Resource

Tools